Determination of barriers to rotation of axially chiral 5-methyl-2-(o-aryl)imino-3-(o-aryl)thiazolidine-4-ones

Chirality

Volumn 24, Issue 6, 2012, Pages 493-498

  Erol, Sule ^a   Dogan, Ilknur ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

Author keywords

axial chirality; barrier to rotation; enantioselective HPLC; hindered rotation; separation of diastereomers; thermal interconversion

Indexed keywords

5 METHYL 2 (O ARYL)IMINO 3 (O ARYL)THIAZOLIDINE 4 ONE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; CONFORMATION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ROTATION; STEREOCHEMISTRY;

EID: 84861579914     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22007     Document Type: Article

References (17)

1. Chen Y, Yekta S, Yudin AK,. Modified BINOL ligands in asymmetric catalysis. Chem Rev 2003; 103: 3155-3211.
2. Dai X, Wong A, Virgil SC,. Synthesis and resolution of quinazolinone atropisomeric phosphine ligands. J Org Chem 1998; 63: 2597-2600.
3. Dai X, Virgil S,. Asymmetric allylic alkylation catalyzed by palladium complexes with atropisomeric quinazolinone phosphine ligands. Tetrahedron Lett 1999; 40: 1245-1248.
4. Dai X, Virgil S,. Synthesis of 2-heterosubstituted quinazolinone atropisomeric phosphine ligands by direct lithiation of a 2-unsubstituted quinazolinone system. Tetrahedron: Asymmetry 1999; 10: 25-29.
5. Chen Y, Smith MD, Shimizu KD,. An axially chiral phosphine ligand based on restricted rotation in N-arylimides. Tetrahedron Lett 2001; 42: 7185-7187.
6. (amine) bond atropisomeric aminophosphine: preparation and use as a ligand in a catalytic asymmetric allylic alkylation. Tetrahedron: Asymmetry 2003; 14: 2503-2506.
7. (amine) bonds for use as ligands in asymmetric catalysis. J Org Chem 2006; 71: 7346-7353.
8. Bringmann G, Gulder T, Gulder TAM, Breuning M,. Atroposelective total synthesis of axially chiral biaryl natural products. Chem Rev 2011; 111: 563-639.
9. Romine JL, Laurent DR, Leet JE, Martin SW, Serrano-Wu MH, Yang F, Gao M, O' Boyle DR, Lemm JA, Sun JH, Nower PT, Huang X, Deshpande MS, Meanwell NA, Snyder LB,. Inhibitors of HCV NS5A: from iminothiazolidinones to symmetrical stilbenes. ACS Med Chem Lett 2011; 2: 224-229.
10. Bolli MH, Abele S, Binkert C, Bravo R, Buchmann S, Bur D, Gatfield J, Hess P, Kohl C, Mangold C, Mathys B, Menyhart K, Muller C, Nayler O, Scherz M, Schmidt G, Sippel V, Steiner B, Strasser D, Treiber A, Weller T,. 2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J Med Chem 2010; 53: 4198-4211.
11. Pan B, Huang RZ, Han SQ, Qub D, Zhu ML, Wei P, Ying HJ,. Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones. Bioorg Med Chem Lett 2010; 20: 2461-2464.
12. Erol S, Dogan I,. Axially chiral 2-arylimino-3-aryl-thiazolidine-4-one derivatives: enantiomeric separation and determination of racemization barriers by chiral HPLC. J Org Chem 2007; 72: 2494-2500.
13. Demir O, Dogan I,. Conformational preferences in diastereomeric (5S)-methyl-3-(o-aryl)-2,4-oxazolidinediones. Chirality 2003; 15: 242-250.
14. Yilmaz EM, Dogan I,. Axially chiral N-(o-aryl)-2-thioxo-oxazolidine-4-one and rhodanine derivatives: enantiomeric separation and determination of racemization barriers. Tetrahedron: Asymmetry 2008; 19: 2184-2191.
15. Bouchekara M, Djafri A, Vanthuyne N, Roussel C,. Atropisomerism in some N,N'-diaryl-2-iminothiazoline derivatives: chiral separation and configurational stability. Arkivoc 2002; 10: 72-79.
16. Roussel C, Vanthuyne N, Shineva N, Bouchekara M, Djafric A,. Atropisomerism in the 2-arylimino-N-(2-aryl)-thiazoline series. Arkivoc 2008; 8: 28-41.
17. Roussel C, Vanthuyne N, Bouchekara M, Djafri A, Elguero J, Alkorta I,. Atropisomerism in the 2-arylimino-N-(2-hydroxyphenyl)thiazoline series: influence of hydrogen bonding on the racemization process. J Org Chem 2008; 73: 403-411.